GlassScriptPhysician profile
David Barton Sills
NPI 1063409878
$1,475.49
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2020: $128 · 2021: $372 · 2022: $235 · 2023: $187 · 2024: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $350.94 | 2021-2024 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $297.41 | 2019-2022 | |
| Lilly USA, LLC | $235.20 | 2020-2024 | Mounjaro, Zepbound |
| Astellas Pharma US INC | $137.53 | 2019-2023 | Veozah |
| Pfizer INC. | $72.56 | 2019-2020 | |
| Allergan, INC. | $54.28 | 2019 | |
| Abbott Laboratories | $45.00 | 2022-2024 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.51 | 2019 | |
| Novartis Pharmaceuticals Corporation | $31.34 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $30.78 | 2019-2020 | |
| Alfasigma USA, INC. | $25.26 | 2021 | |
| Valeritas, INC. | $20.10 | 2019 | |
| Amarin Pharma, INC. | $18.92 | 2019 | |
| Novo Nordisk INC | $18.26 | 2019 | |
| Glaxosmithkline, LLC. | $16.76 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $16.36 | 2019 | |
| Abiomed | $15.65 | 2024 | Impella |
| Phathom Pharmaceuticals, INC. | $14.47 | 2024 | Voquezna |
| Amgen INC. | $13.94 | 2023 | Repatha |
| Alnylam Pharmaceuticals INC. | $13.23 | 2024 | Givlaari |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sills listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.